Really nice to be hosting the BASL #MASLD SIG at Jesus College Oxford on 5th September 📢Attendance is FREE and registration is EASY. There are still a few spaces left. 🔗(tinyurl.com/4j8esadr) Really great mix of speakers. AM = Basic/Translational science; PM = Clinical updates
Tom Marjot
@tom-marjot.bsky.social
Liver doctor. NIHR Academic Clinical Lecturer at University of Oxford. Interested in #MASLD, #circadian rhythms, & #sleep. #EASL YI Taskforce.
📢Great to write this review for Hep Comms with Matt Armstrong & @jonathanstinemd.bsky.social 💪We've covered everything you need to know about #Muscle & #MASLD - Insulin resistance - Sarcopenia - Myosteatosis - Impact of weight loss drugs - Benefits of exercise 🔗 shorturl.at/aFO1Q #LiverSky
It was an absolute delight to contribute to this high-impact work with @tom-marjot.bsky.social and @mattarmstrong95.bsky.social in which we review all things #MASLD and #Muscle! If you're looking for holiday weekend reading, look no further: journals.lww.com/hepcomm/page... @ebtapper.bsky.social
Skeletal muscle and MASLD: Mechanistic and clinical insights : Hepatology Communications
, which all converge on the liver to drive disease progression and adverse patient outcomes. This review explores the mechanistic links between skeletal muscle and MASLD, including the role of abnorma...
journals.lww.com
BS @easlnews.bsky.social Congress Wed 7🗓️Whole-day seminar plus a wet lab on spatial biology (NEW THIS YEAR‼️) Thu 8🗓️State of the Art by Lars Zender Fri 9🗓️MTE sessions on MASLD & MetALD Sat 10🗓️Microbiome session co-chaired by our own @debbieshawcross.bsky.social & more!🔗https://tinyurl.com/4ky9r3x9
In these unprecedented dark times for American life science and medical research (no less well beyond biomedicine), my coping mechanism is to laser focus on the unremitting and remarkable daily advances, and the fervent hope these will not be slowed or interrupted.
Breakthroughs Beyond the Journal @jhepatology.bsky.social 🚨The liver is central to fructose-associated cancer ▶️Tumors cannot use fructose directly ▶️Liver converts to specific lipids (LPC) ▶️LPCs integrate into new cancer membranes Can this explain link between MASLD & extra-hepatic cancer?
Breakthroughs Beyond the Journal @jhepatology.bsky.social 🚨The liver is central to fructose-associated cancer ▶️Tumors cannot use fructose directly ▶️Liver converts to specific lipids (LPC) ▶️LPCs integrate into new cancer membranes Can this explain link between MASLD & extra-hepatic cancer?
Young Investigator Poster Tour @easlnews.bsky.social #SLDSummit Huge attendance and interest! 👏🏼 @tom-marjot.bsky.social @madsisraelsen.bsky.social
2025 is the perfect year to take your career to the next level🚀 There are also 6 positions to fill in the EASL Scientific Committee, Policy Public Health and Advocacy Committee, Ethics and Compliance Committee and Nurses & AHPs Task Force. Apply by 20 January: easl.eu/leadership25 #LiverSky
By @adhanda.bsky.social & @tom-marjot.bsky.social #Sharedit link: rdcu.be/d5rwu
Alcohol-free and low-strength drinks: friend or foe?
Nature Reviews Gastroenterology & Hepatology - Consumption of no and low-alcohol (NoLo) beverages is now commonplace in modern society. However, the debate surrounding the relative risks and...
rdcu.be
Thoughtful piece from Marjot & Dhanda (@adhanda.bsky.social) in @natrevgastrohep.bsky.social: Alcohol-free drinks show promise for motivated individuals to reduce alcohol consumption but may pose relapse risks in others. Balance is key for clinical guidance. 🧪 www.nature.com/articles/s41...
Thoughtful piece from Marjot & Dhanda (@adhanda.bsky.social) in @natrevgastrohep.bsky.social: Alcohol-free drinks show promise for motivated individuals to reduce alcohol consumption but may pose relapse risks in others. Balance is key for clinical guidance. 🧪 www.nature.com/articles/s41...
Alcohol-free and low-strength drinks: friend or foe? - Nature Reviews Gastroenterology & Hepatology
Consumption of no and low-alcohol (NoLo) beverages is now commonplace in modern society. However, the debate surrounding the relative risks and benefits of these products is nuanced and evolving, part...
nature.com
Hello, #MedSky community! We’re excited to begin our Bluesky journey. Here is a sampling of the trusted, influential, and essential information you can expect when you follow us:
#LiverSky Come join in T-minus 26 mins for EASL Studio! #Sarcopenia #Exercise #Nutrition #Frailty #MASLD #LiverTransplant
💪 Excited to join as a panelist alongside #ShelleyKeating #FelicityWilliams #JenniferLai for Episode 8 of @EASLnews #EASLStudio2024 discussing #Sarcopenia in chronic liver disease on Wed Nov 27! Don’t miss it! #LiverHealth #Hepatology #ClinicalPractice easl.eu/easl-studio-...
Tumor seeding is a dreaded complication of biopsy for HCC. But how common is it? A systematic review in @amcollegegastro.bsky.social #AmJGastro reports a rate of tumor seeding of 0.62% with even lower rates in recent years #LiverSky Link: journals.lww.com/ajg/abstract...
#LiverSky Useful tip... There's no 'bookmark' function in Bluesky currently. But there is a nice work-around: 1) Reply to the post of interest with a📌emoji 2) Click on this link bsky.app/profile/did:... 3) Click 'Pin to Home' This will collate📌posts in a tab on your home screen + ⬆️ engagement.
1/3 What happens when science and every day clinical practice comes together? A 🧵 You get a packed room with not even a place to stand 👇🏼 Why? I firmly believe that we need to bridge the gap between research and clinical application in our scientific meetings. #TLM24
This artwork was published in the Journal of Immunology, published by @immunologyaai.bsky.social - which appears not to give a fork. pubpeer.com/publications... The Chinese government also did not see any problem. www.science.org/content/arti... #ThisImageIsFine
We are on our second starter pack for GI / Hepatology Part 1: go.bsky.app/8Pho2tp Part 2: go.bsky.app/VGyLKjR #medsky #GIsky #LiverSky